- Home
- MAA vs RLAY Comparison
MAA vs RLAY Comparison
Compare MAA & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAA | RLAY |
|---|---|---|
| Founded | 1977 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8B | 2.5B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | MAA | RLAY |
|---|---|---|
| Price | $129.87 | $14.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 10 |
| Target Price | ★ $147.33 | $19.50 |
| AVG Volume (30 Days) | 748.6K | ★ 3.7M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.72% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $2.67 | N/A |
| Revenue Next Year | $2.91 | $324.03 |
| P/E Ratio | $35.71 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $120.30 | $2.93 |
| 52 Week High | $156.23 | $17.32 |
Technical Indicators
Market Signals| Indicator | MAA | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 53.06 | 56.54 |
| Support Level | $125.45 | $11.68 |
| Resistance Level | $132.40 | $15.45 |
| Average True Range (ATR) | 2.06 | 0.96 |
| MACD | 0.06 | 0.14 |
| Stochastic Oscillator | 67.78 | 62.40 |
Price Performance
Historical ComparisonAbout MAA Mid-America Apartment Communities Inc.
Mid-America Apartment Communities Inc is a multifamily-focused, self-administered and self-managed real estate investment trust. The company owns, operates, acquires and selectively develops apartment communities located in the Southeast, Southwest and Mid-Atlantic regions of the U.S. Its business objectives are to generate a sustainable, stable and increasing cash flow that will fund its dividends and distributions through all parts of the real estate investment cycle. It operates in two segments, Same Store and Non-Same Store and Other. The majority of the revenue is derived from Same Store segment.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.